- €1.07bn
- €1.43bn
- €1.12bn
- 62
- 59
- 18
- 40
Annual balance sheet for Jenoptik AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | C2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 70.7 | 62 | 59.7 | 71.2 | 88.3 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 226 | 227 | 226 | 225 | 233 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 490 | 646 | 543 | 567 | 589 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 263 | 267 | 325 | 365 | 420 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,339 | 1,757 | 1,672 | 1,667 | 1,740 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 416 | 473 | 309 | 268 | 261 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 661 | 989 | 840 | 770 | 780 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 678 | 768 | 832 | 897 | 960 |
| Total Liabilities & Shareholders' Equity | 1,339 | 1,757 | 1,672 | 1,667 | 1,740 |
| Total Common Shares Outstanding |